Basics |
Gossamer Bio, Inc.
|
IPO Date: |
February 4, 2019 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$329.59M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.26 | 3.55%
|
Avg Daily Range (30 D): |
$0.05 | 3.27%
|
Avg Daily Range (90 D): |
$0.05 | 4.18%
|
Institutional Daily Volume |
Avg Daily Volume: |
1.09M |
Avg Daily Volume (30 D): |
1.87M |
Avg Daily Volume (90 D): |
1.58M |
Trade Size |
Avg Trade Size (Sh.): |
172 |
Avg Trade Size (Sh.) (30 D): |
231 |
Avg Trade Size (Sh.) (90 D): |
222 |
Institutional Trades |
Total Inst.Trades: |
1,269 |
Avg Inst. Trade: |
$1.46M |
Avg Inst. Trade (30 D): |
$5.27M |
Avg Inst. Trade (90 D): |
$5.27M |
Avg Inst. Trade Volume: |
.26M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$1.73M |
Avg Closing Trade (30 D): |
$19.93M |
Avg Closing Trade (90 D): |
$19.93M |
Avg Closing Volume: |
328.17K |
|
|
Financials |
|
TTM |
Q1 2025 |
Q4 2024 |
Basic EPS
|
$-.23
|
$-.16
|
$-.15
|
Diluted EPS
|
$-.23
|
$-.16
|
$-.15
|
Revenue
|
$ 124.59M
|
$ 9.89M
|
$ 9.38M
|
Gross Profit
|
$
|
$
|
$
|
Net Income / Loss
|
$ -51.24M
|
$ -36.64M
|
$ -33.03M
|
Operating Income / Loss
|
$ -54.77M
|
$ -36.81M
|
$ -36.13M
|
Cost of Revenue
|
$
|
$
|
$
|
Net Cash Flow
|
$ -9.91M
|
$ -17.16M
|
$ 17.74M
|
PE Ratio
|
|
|
|
|
|
|